Cai‐Guang Yang

9.5k total citations · 3 hit papers
115 papers, 6.4k citations indexed

About

Cai‐Guang Yang is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Cai‐Guang Yang has authored 115 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Molecular Biology, 30 papers in Organic Chemistry and 16 papers in Infectious Diseases. Recurrent topics in Cai‐Guang Yang's work include RNA modifications and cancer (28 papers), Antimicrobial Resistance in Staphylococcus (13 papers) and Biochemical and Structural Characterization (12 papers). Cai‐Guang Yang is often cited by papers focused on RNA modifications and cancer (28 papers), Antimicrobial Resistance in Staphylococcus (13 papers) and Biochemical and Structural Characterization (12 papers). Cai‐Guang Yang collaborates with scholars based in China, United States and Germany. Cai‐Guang Yang's co-authors include Chuan He, Chuan He, Biao Jiang, Yue Huang, Junliang Zhang, Chengqi Yi, Guifang Jia, Jianhua Gan, Xing Jian and Zhike Lu and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Cai‐Guang Yang

110 papers receiving 6.3k citations

Hit Papers

m6A RNA Methylation Regulates the Self-Renewal and Tumori... 2014 2026 2018 2022 2017 2014 2021 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cai‐Guang Yang China 40 4.3k 1.7k 1.6k 615 368 115 6.4k
Nicole S. Sampson United States 40 3.0k 0.7× 961 0.6× 431 0.3× 70 0.1× 426 1.2× 127 4.4k
Maosheng Cheng China 36 2.7k 0.6× 2.1k 1.3× 315 0.2× 236 0.4× 674 1.8× 387 5.7k
Jingxin Wang United States 32 1.8k 0.4× 593 0.4× 437 0.3× 213 0.3× 329 0.9× 85 3.1k
Chloé Zubieta France 35 3.4k 0.8× 239 0.1× 357 0.2× 761 1.2× 234 0.6× 85 5.7k
Thomas E. Nielsen Denmark 33 3.3k 0.8× 2.5k 1.5× 164 0.1× 168 0.3× 425 1.2× 112 5.2k
Yukio Kitade Japan 32 2.5k 0.6× 938 0.6× 805 0.5× 59 0.1× 273 0.7× 245 4.1k
Yongcheng Song United States 42 2.9k 0.7× 1.0k 0.6× 250 0.2× 134 0.2× 697 1.9× 106 4.9k
Scott G. Stewart Australia 31 1.6k 0.4× 1.4k 0.8× 336 0.2× 162 0.3× 296 0.8× 88 3.5k
Norton P. Peet United States 37 1.5k 0.4× 2.1k 1.3× 126 0.1× 144 0.2× 318 0.9× 190 4.2k
J.P. Turkenburg United Kingdom 43 5.2k 1.2× 1.0k 0.6× 68 0.0× 241 0.4× 200 0.5× 121 7.1k

Countries citing papers authored by Cai‐Guang Yang

Since Specialization
Citations

This map shows the geographic impact of Cai‐Guang Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cai‐Guang Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cai‐Guang Yang more than expected).

Fields of papers citing papers by Cai‐Guang Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cai‐Guang Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cai‐Guang Yang. The network helps show where Cai‐Guang Yang may publish in the future.

Co-authorship network of co-authors of Cai‐Guang Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Cai‐Guang Yang. A scholar is included among the top collaborators of Cai‐Guang Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cai‐Guang Yang. Cai‐Guang Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Zhengxuan, Ziqi Yuan, Qiuyu Zhu, et al.. (2025). Modular Synthesis of the Potent Antibiotic Amycolamicin and Diastereomeric Analogues Thereof. Organic Letters. 27(14). 3631–3636.
2.
Yang, Teng, Ze Dong, Yiqing Wang, et al.. (2025). Development of Orally Bioavailable FTO Inhibitors with Potent Antileukemia Efficacy. Journal of Medicinal Chemistry. 68(13). 13714–13727. 1 indexed citations
3.
Li, Yali, et al.. (2024). A covalent compound selectively inhibits RNA demethylase ALKBH5 rather than FTO. RSC Chemical Biology. 5(4). 335–343. 24 indexed citations
4.
Wang, Pengyu, Yanling Zhao, Min Zhang, et al.. (2024). Structure-guided development of selective caseinolytic protease P agonists as antistaphylococcal agents. Cell Reports Medicine. 5(12). 101837–101837. 1 indexed citations
5.
Zhang, Min, et al.. (2024). Synthesis and antibacterial activities of heterocyclic ring-fused 20(S)-protopanaxadiol derivatives. Bioorganic & Medicinal Chemistry. 112. 117901–117901. 3 indexed citations
6.
Cheng, Yu‐Ting, Ziqi Yuan, Haotian Li, et al.. (2024). Expeditious Synthesis of Gwanakoside A and the Chloronaphthol Glycoside Congeners. Organic Letters. 26(12). 2425–2429. 1 indexed citations
7.
Yan, Chao Guo, Qian Zhang, Pan Xiao, et al.. (2024). Structure‐Activity Relationships of 2‐(Arylthio)benzoic Acid FTO Inhibitors. Israel Journal of Chemistry. 64(3-4). 4 indexed citations
8.
Zhu, Heping, Xiaomin Song, Ming Li, et al.. (2023). Design, synthesis, and biological evaluation of novel spirocyclic compounds as potential anti-glioblastoma agents. European Journal of Medicinal Chemistry. 258. 115595–115595. 4 indexed citations
9.
Huang, Yue, et al.. (2023). Chemical Inhibitors Targeting the Oncogenic m6A Modifying Proteins. Accounts of Chemical Research. 56(21). 3010–3022. 46 indexed citations
10.
Xiao, Pan, Liang Chen, Lu Liu, et al.. (2023). Rational Design of RNA Demethylase FTO Inhibitors with Enhanced Antileukemia Drug-Like Properties. Journal of Medicinal Chemistry. 66(14). 9731–9752. 33 indexed citations
11.
Xiao, Pan, Tao Zhang, Hongjiao Xu, et al.. (2022). Structure–Activity Relationships and Antileukemia Effects of the Tricyclic Benzoic Acid FTO Inhibitors. Journal of Medicinal Chemistry. 65(15). 10638–10654. 35 indexed citations
12.
Wang, Pengyu, Min Zhang, Quanjiang Ji, et al.. (2022). Anti-infective therapy using species-specific activators of Staphylococcus aureus ClpP. Nature Communications. 13(1). 6909–6909. 29 indexed citations
13.
Zhou, Linlin, Hongjiao Xu, Yue Huang, & Cai‐Guang Yang. (2021). Targeting the RNA demethylase FTO for cancer therapy. RSC Chemical Biology. 2(5). 1352–1369. 41 indexed citations
14.
Zhou, Linlin, et al.. (2020). RNA Methylation m6A: A New Code and Drug Target?. Chinese Journal of Chemistry. 38(4). 420–421. 13 indexed citations
15.
Chen, Biao, Yongliang Zhao, Peiyi Wang, et al.. (2019). Sulfone-Based Probes Unraveled Dihydrolipoamide S-Succinyltransferase as an Unprecedented Target in Phytopathogens. Journal of Agricultural and Food Chemistry. 67(25). 6962–6969. 26 indexed citations
16.
Zhang, Zhang, Liqian Chen, Yuli Zhao, et al.. (2019). Single-base mapping of m 6 A by an antibody-independent method. Science Advances. 5(7). eaax0250–eaax0250. 291 indexed citations
17.
Zhang, Wenming, Yang Yao, Teng Yang, et al.. (2018). The synthesis and antistaphylococcal activity of N-sulfonaminoethyloxime derivatives of dehydroabietic acid. Bioorganic & Medicinal Chemistry Letters. 28(10). 1943–1948. 16 indexed citations
18.
Ye, Fei, et al.. (2016). The development of small-molecule modulators for ClpP protease activity. Molecular BioSystems. 13(1). 23–31. 45 indexed citations
19.
Chen, Hao, Chengqi Yi, Jin Zhang, et al.. (2010). Structural insight into the oxidation‐sensing mechanism of the antibiotic resistance of regulator MexR. EMBO Reports. 11(9). 685–690. 43 indexed citations
20.
Chen, Baoen, Hongchuan Liu, Xiaoxu Sun, & Cai‐Guang Yang. (2010). Mechanistic insight into the recognition of single-stranded and double-stranded DNA substrates by ABH2 and ABH3. Molecular BioSystems. 6(11). 2143–2149. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026